Gilead Sciences Inc (GILD)
64.78
-0.55
(-0.84%)
USD |
NASDAQ |
May 03, 16:00
64.79
+0.01
(+0.02%)
After-Hours: 20:00
Gilead Sciences Market Cap: 80.78B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 80.78B |
| May 02, 2024 | 81.46B |
| May 01, 2024 | 81.69B |
| April 30, 2024 | 81.30B |
| April 29, 2024 | 82.23B |
| April 26, 2024 | 81.58B |
| April 25, 2024 | 81.39B |
| April 24, 2024 | 83.65B |
| April 23, 2024 | 83.58B |
| April 22, 2024 | 83.48B |
| April 19, 2024 | 83.25B |
| April 18, 2024 | 82.50B |
| April 17, 2024 | 83.46B |
| April 16, 2024 | 83.93B |
| April 15, 2024 | 84.48B |
| April 12, 2024 | 84.88B |
| April 11, 2024 | 85.60B |
| April 10, 2024 | 84.94B |
| April 09, 2024 | 87.21B |
| April 08, 2024 | 86.56B |
| April 05, 2024 | 86.76B |
| April 04, 2024 | 86.73B |
| April 03, 2024 | 88.40B |
| April 02, 2024 | 89.89B |
| April 01, 2024 | 90.88B |
| Date | Value |
|---|---|
| March 28, 2024 | 91.34B |
| March 27, 2024 | 91.04B |
| March 26, 2024 | 90.29B |
| March 25, 2024 | 90.51B |
| March 22, 2024 | 90.54B |
| March 21, 2024 | 91.14B |
| March 20, 2024 | 92.25B |
| March 19, 2024 | 91.54B |
| March 18, 2024 | 91.35B |
| March 15, 2024 | 91.89B |
| March 14, 2024 | 92.40B |
| March 13, 2024 | 94.55B |
| March 12, 2024 | 93.48B |
| March 11, 2024 | 93.78B |
| March 08, 2024 | 93.53B |
| March 07, 2024 | 91.71B |
| March 06, 2024 | 90.43B |
| March 05, 2024 | 90.88B |
| March 04, 2024 | 89.96B |
| March 01, 2024 | 90.03B |
| February 29, 2024 | 89.77B |
| February 28, 2024 | 90.57B |
| February 27, 2024 | 90.97B |
| February 26, 2024 | 90.88B |
| February 23, 2024 | 91.63B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
71.01B
Minimum
Dec 30 2020
112.22B
Maximum
Dec 08 2022
88.07B
Average
85.56B
Median
Dec 12 2019
Market Cap Benchmarks
| Amgen Inc | 166.99B |
| CymaBay Therapeutics Inc (DELISTED) | -- |
| Bristol-Myers Squibb Co | 89.17B |
| Eli Lilly and Co | 698.52B |
| Xilio Therapeutics Inc | 40.68M |
Market Cap Related Metrics
| PE Ratio | 179.94 |
| PS Ratio | 2.96 |
| Price to Book Value | 4.628 |
| Price to Free Cash Flow | 9.580 |
| Price | 64.78 |
| Earnings Yield | 0.56% |
| Operating PE Ratio | 12.63 |
| Normalized PE Ratio | 16.60 |